naturalX Health Ventures is a €100 million venture capital fund backed by the Schwabe Group, focused on consumer health startups at the intersection of wellness and medicine. The firm invests at Series A and Series B stages across Europe and the U.S.
60% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 3 prior). Their most common stage is series-b (60% of deals). Average disclosed round size is $35.7M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
$105M
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Jutro Medical | Series A | — | Dec 2025 |
| AAktiia | Series B | $42M | May 2025 |
 Hilo | Series B | $42M | May 2025 |
 Kyan Health | Series A | $16.7M | Nov 2024 |
| HHilo | Series B | $42M | — |
Top Co-Investors
Wellington Management3 shared
Molten Ventures3 shared
Translink Capital3 shared
Redalpine3 shared
Verve Ventures3 shared
Khosla Ventures3 shared
Kfund3 shared
Earlybird Venture Capital2 shared
Amplo1 shared
GreyMatter Capital1 shared
Founderful1 shared
Joyance Partners1 shared
private angel investors1 shared
Swisscom Ventures1 shared
Kaya VC1 shared
Vinci Venture Capital1 shared
Warsaw Equity Group1 shared
Inovo1 shared
Fuel Ventures1 shared
Motier Ventures1 shared
Last updated: 20 October 2026